The focus of this study was to determine the effects of GSK3β and investigate its molecular mechanism of action, specifically via the GSK3β-CXCR4/MMP-2 pathway, in PANC1 pancreatic cancer cells. The gene discussed is CXCR4; the disease is familial pancreatic carcinoma.